Literature DB >> 23940003

Generation and characterization of spiking and nonspiking oligodendroglial progenitor cells from embryonic stem cells.

Peng Jiang1, Chen Chen, Xiao-Bo Liu, Vimal Selvaraj, Wei Liu, Daniel H Feldman, Ying Liu, David E Pleasure, Ronald A Li, Wenbin Deng.   

Abstract

Pluripotent stem cells (PSCs) have been differentiated into oligodendroglial progenitor cells (OPCs), providing promising cell replacement therapies for many central nervous system disorders. Studies from rodents have shown that brain OPCs express a variety of ion channels, and that a subset of brain OPCs express voltage-gated sodium channel (NaV ), mediating the spiking properties of OPCs. However, it is unclear whether PSC-derived OPCs exhibit electrophysiological properties similar to brain OPCs and the role of NaV in the functional maturation of OPCs is unknown. Here, using a mouse embryonic stem cell (mESC) green fluorescent protein (GFP)-Olig2 knockin reporter line, we demonstrated that unlike brain OPCs, all the GFP(+) /Olig2(+) mESC-derived OPCs (mESC-OPCs) did not express functional NaV and failed to generate spikes (hence termed "nonspiking mESC-OPCs"), while expressing the delayed rectifier and inactivating potassium currents. By ectopically expressing NaV 1.2 α subunit via viral transduction, we successfully generated mESC-OPCs with spiking properties (termed "spiking mESC-OPCs"). After transplantation into the spinal cord and brain of myelin-deficient shiverer mice, the spiking mESC-OPCs demonstrated better capability in differentiating into myelin basic protein expressing oligodendrocytes and in myelinating axons in vivo than the nonspiking mESC-OPCs. Thus, by generating spiking and nonspiking mESC-OPCs, this study reveals a novel function of NaV in OPCs in their functional maturation and myelination, and sheds new light on ways to effectively develop PSC-derived OPCs for future clinical applications. © AlphaMed Press.

Entities:  

Keywords:  Action potential; Embryonic stem cell; Myelination; Oligodendroglial progenitor cell; Voltage-gated ion channel

Mesh:

Year:  2013        PMID: 23940003      PMCID: PMC3923867          DOI: 10.1002/stem.1515

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  61 in total

1.  Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes.

Authors:  P C Buttery; C ffrench-Constant
Journal:  Mol Cell Neurosci       Date:  1999-09       Impact factor: 4.314

2.  NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration.

Authors:  Shin H Kang; Masahiro Fukaya; Jason K Yang; Jeffrey D Rothstein; Dwight E Bergles
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

3.  Oligodendrocyte progenitor cells derived from mouse embryonic stem cells give rise to type-1 and type-2 astrocytes in vitro.

Authors:  Chen Chen; Daniel Daugherty; Peng Jiang; Wenbin Deng
Journal:  Neurosci Lett       Date:  2012-07-07       Impact factor: 3.046

4.  Differentiation of human oligodendrocytes from pluripotent stem cells.

Authors:  Bao-Yang Hu; Zhong-Wei Du; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

5.  Ca(2+) signaling evoked by activation of Na(+) channels and Na(+)/Ca(2+) exchangers is required for GABA-induced NG2 cell migration.

Authors:  Xiao-ping Tong; Xiang-yao Li; Bing Zhou; Wanhua Shen; Zhi-jun Zhang; Tian-le Xu; Shumin Duan
Journal:  J Cell Biol       Date:  2009-07-13       Impact factor: 10.539

6.  Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.

Authors:  Su Wang; Janna Bates; Xiaojie Li; Steven Schanz; Devin Chandler-Militello; Corri Levine; Nimet Maherali; Lorenz Studer; Konrad Hochedlinger; Martha Windrem; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2013-02-07       Impact factor: 24.633

7.  Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects.

Authors:  Bao-Yang Hu; Zhong-Wei Du; Xue-Jun Li; Melvin Ayala; Su-Chun Zhang
Journal:  Development       Date:  2009-05       Impact factor: 6.868

8.  Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse.

Authors:  Laura E Clarke; Kaylene M Young; Nicola B Hamilton; Huiliang Li; William D Richardson; David Attwell
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

9.  Differentiation of embryonic stem cells into oligodendrocyte precursors.

Authors:  Peng Jiang; Vimal Selvaraj; Wenbin Deng
Journal:  J Vis Exp       Date:  2010-05-19       Impact factor: 1.355

10.  Transplantation of oligodendrocyte precursor cells improves locomotion deficits in rats with spinal cord irradiation injury.

Authors:  Yan Sun; Chong-Chong Xu; Jin Li; Xi-Yin Guan; Lu Gao; Li-Xiang Ma; Rui-Xi Li; Yu-Wen Peng; Guo-Pei Zhu
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more
  14 in total

1.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

2.  Humanized neuronal chimeric mouse brain generated by neonatally engrafted human iPSC-derived primitive neural progenitor cells.

Authors:  Chen Chen; Woo-Yang Kim; Peng Jiang
Journal:  JCI Insight       Date:  2016-11-17

Review 3.  A matter of space and time: Emerging roles of disease-associated proteins in neural development.

Authors:  Georgia Panagiotakos; Sergiu P Pasca
Journal:  Neuron       Date:  2021-11-29       Impact factor: 17.173

4.  Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion.

Authors:  Peng Jiang; Chen Chen; Xiao-Bo Liu; David E Pleasure; Ying Liu; Wenbin Deng
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

5.  Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke.

Authors:  Jian Xu; Jingxin Zhao; Rui Wang; Yidi Zhang; Lan Shen; Qian Xiao; Yuan Xie; Jinjun Jiang; Yichu Nie; Wenbin Deng
Journal:  Theranostics       Date:  2022-03-28       Impact factor: 11.600

6.  Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.

Authors:  Shweta Bagewadi Kawalia; Tamara Raschka; Mufassra Naz; Ricardo de Matos Simoes; Philipp Senger; Martin Hofmann-Apitius
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model.

Authors:  Hong-Bin Fan; Li-Xia Chen; Xue-Bin Qu; Chuan-Lu Ren; Xiu-Xiang Wu; Fu-Xing Dong; Bao-Le Zhang; Dian-Shuai Gao; Rui-Qin Yao
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

Review 8.  Tissue engineered scaffolds in regenerative medicine.

Authors:  Mohsen Hosseinkhani; Davood Mehrabani; Mohammad Hassan Karimfar; Salar Bakhtiyari; Amir Manafi; Reza Shirazi
Journal:  World J Plast Surg       Date:  2014-01

9.  Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells.

Authors:  Chen Chen; Peng Jiang; Haipeng Xue; Suzanne E Peterson; Ha T Tran; Anna E McCann; Mana M Parast; Shenglan Li; David E Pleasure; Louise C Laurent; Jeanne F Loring; Ying Liu; Wenbin Deng
Journal:  Nat Commun       Date:  2014-07-18       Impact factor: 14.919

10.  Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.

Authors:  Matthew R Livesey; Dario Magnani; Elaine M Cleary; Navneet A Vasistha; Owain T James; Bhuvaneish T Selvaraj; Karen Burr; David Story; Christopher E Shaw; Peter C Kind; Giles E Hardingham; David J A Wyllie; Siddharthan Chandran
Journal:  Stem Cells       Date:  2016-01-13       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.